TreeWAS – Variant ID: rs3916164

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E11.4 With neurological complications	0.287	0.713	0.000
E11.9 Without complications	0.273	0.727	0.000
E11 Non-insulin-dependent diabetes mellitus	0.268	0.732	0.000
E11.2 With renal complications	0.232	0.768	0.000
E11.0 With coma	0.214	0.786	0.000
E11.5 With peripheral circulatory complications	0.197	0.803	0.000
E11.7 With multiple complications	0.192	0.808	0.000
E11.1 With ketoacidosis	0.147	0.853	0.000
E11.8 With unspecified complications	0.135	0.865	0.000
E10-E14 Diabetes mellitus	0.111	0.889	0.000
E11.3 With ophthalmic complications	0.106	0.894	0.000
E11.6 With other specified complications	0.098	0.901	0.000
E14 Unspecified diabetes mellitus	0.093	0.907	0.000
E13 Other specified diabetes mellitus	0.087	0.913	0.000
E12 Malnutrition-related diabetes mellitus	0.079	0.920	0.000
E14.3 With ophthalmic complications	0.077	0.923	0.000
E14.8 With unspecified complications	0.076	0.924	0.000
E14.6 With other specified complications	0.073	0.926	0.000
E14.2 Withrenal complications	0.068	0.931	0.000
E13.3 With ophthalmic complications	0.068	0.932	0.000
E14.4 With neurological complications	0.067	0.933	0.000
E14.7 With multiple complications	0.066	0.933	0.000
E14.0 With coma	0.066	0.933	0.000
E13.9 Without complications	0.065	0.935	0.000
E14.5 With peripheral circulatory complications	0.065	0.935	0.000
E13.8 With unspecified complications	0.062	0.937	0.000
E13.7 With multiple complications	0.062	0.937	0.000
E13.6 With other specified complications	0.062	0.937	0.000
E13.5 With peripheral circulatory complications	0.062	0.937	0.000
E13.4 With neurological complications	0.062	0.937	0.000
E13.2 With renal complications	0.062	0.937	0.000
E13.1 With ketoacidosis	0.062	0.937	0.000
E13.0 With coma	0.062	0.937	0.000
E14.9 Without complications	0.061	0.939	0.000
E12.9 Without complications	0.057	0.943	0.000
E12.8 With unspecified complications	0.057	0.943	0.000
E12.7 With multiple complications	0.057	0.943	0.000
E12.6 With other specified complications	0.057	0.943	0.000
E12.5 With peripheral circulatory complications	0.057	0.943	0.000
E12.4 With neurological complications	0.057	0.943	0.000
E12.3 With ophthalmic complications	0.057	0.943	0.000
E12.2 With renal complications	0.057	0.943	0.000
E12.1 With ketoacidosis	0.057	0.943	0.000
E12.0 With coma	0.057	0.943	0.000
O47.1 False labour at or after 37 completed weeks of gestation	0.000	0.944	0.056
E14.1 With ketoacidosis	0.054	0.946	0.000
Z03.5 Observation for other suspected cardiovascular diseases	0.042	0.958	0.000
E10 Insulin-dependent diabetes mellitus	0.038	0.962	0.000
N83.0 Follicular cyst of ovary	0.000	0.962	0.038
N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.000	0.964	0.036
N83.3 Acquired atrophy of ovary and Fallopian tube	0.000	0.965	0.035
N83.2 Other and unspecified ovarian cysts	0.000	0.967	0.033
I34.0 Mitral (valve) insufficiency	0.033	0.967	0.000
E10.4 With neurological complications	0.032	0.968	0.000
E10.5 With peripheral circulatory complications	0.032	0.968	0.000
E10.6 With other specified complications	0.029	0.971	0.000
N83.9 Noninflammatory disorder of ovary, Fallopian tube and broad ligament, unspecified	0.000	0.972	0.028
N83.5 Torsion of ovary, ovarian pedicle and Fallopian tube	0.000	0.972	0.028
E10.7 With multiple complications	0.027	0.972	0.000
E10.2 With renal complications	0.027	0.972	0.000
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.000	0.973	0.027
N83.1 Corpus luteum cyst	0.000	0.974	0.026
N83.7 Haematoma of broad ligament	0.000	0.974	0.026
N83.4 Prolapse and hernia of ovary and Fallopian tube	0.000	0.974	0.026
E10.0 With coma	0.024	0.976	0.000
N83.6 Haematosalpinx	0.000	0.976	0.024
E10.3 With ophthalmic complications	0.022	0.978	0.000
E10.1 With ketoacidosis	0.020	0.979	0.000
E10.8 With unspecified complications	0.020	0.980	0.000
I24.9 Acute ischaemic heart disease, unspecified	0.016	0.984	0.000
G43.9 Migraine, unspecified	0.016	0.984	0.000
E83.4 Disorders of magnesium metabolism	0.015	0.985	0.000
O47 False labour	0.000	0.986	0.014
O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium	0.014	0.986	0.000
N04 Nephrotic syndrome	0.013	0.987	0.000
N04.9 Unspecified	0.013	0.987	0.000
N05 Unspecified nephritic syndrome	0.013	0.987	0.000
N05.1 Focal and segmental glomerular lesions	0.012	0.988	0.000
N05.9 Unspecified	0.012	0.988	0.000
Y60.0 During surgical operation	0.012	0.988	0.000
N00-N08 Glomerular diseases	0.012	0.988	0.000
N04.2 Diffuse membranous glomerulonephritis	0.011	0.989	0.000
N04.0 Minor glomerular abnormality	0.011	0.989	0.000
N02.8 Other	0.011	0.989	0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.010	0.990	0.000
N04.1 Focal and segmental glomerular lesions	0.010	0.990	0.000
N08 Glomerular disorders in diseases classified elsewhere	0.010	0.990	0.000
N02 Recurrent and persistent haematuria	0.010	0.990	0.000
N05.8 Other	0.010	0.990	0.000
N04.8 Other	0.009	0.990	0.000
N04.7 Diffuse crescentic glomerulonephritis	0.009	0.990	0.000
N04.6 Dense deposit disease	0.009	0.990	0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.009	0.990	0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.009	0.990	0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.009	0.990	0.000
N08.3 Glomerular disorders in diabetes mellitus	0.010	0.990	0.000
N05.6 Dense deposit disease	0.009	0.990	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.009	0.990	0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.009	0.990	0.000
N05.0 Minor glomerular abnormality	0.009	0.990	0.000
E10.9 Without complications	0.009	0.991	0.000
G63.2 Diabetic polyneuropathy	0.009	0.991	0.000
O47.0 False labour before 37 completed weeks of gestation	0.000	0.991	0.009
N05.2 Diffuse membranous glomerulonephritis	0.009	0.991	0.000
N00 Acute nephritic syndrome	0.009	0.991	0.000
N07 Hereditary nephropathy, not elsewhere classified	0.009	0.991	0.000
N06 Isolated proteinuria with specified morphological lesion	0.009	0.991	0.000
N01 Rapidly progressive nephritic syndrome	0.009	0.991	0.000
N05.7 Diffuse crescentic glomerulonephritis	0.008	0.992	0.000
N02.0 Minor glomerular abnormality	0.008	0.992	0.000
O47.9 False labour, unspecified	0.000	0.992	0.008
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.008	0.992	0.000
N08.8 Glomerular disorders in other diseases classified elsewhere	0.007	0.992	0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.007	0.992	0.000
N08.1 Glomerular disorders in neoplastic diseases	0.007	0.992	0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.007	0.992	0.000
N02.7 Diffuse crescentic glomerulonephritis	0.007	0.992	0.000
N02.6 Dense deposit disease	0.007	0.992	0.000
N02.5 Diffuse mesangiocapillary glomerulonephritis	0.007	0.992	0.000
N02.4 Diffuse endocapillary proliferative glomerulonephritis	0.007	0.992	0.000
N02.3 Diffuse mesangial proliferative glomerulonephritis	0.007	0.992	0.000
N02.1 Focal and segmental glomerular lesions	0.007	0.992	0.000
M79.86 Other specified soft tissue disorders (Lower leg)	0.007	0.993	0.000
K65.9 Peritonitis, unspecified	0.007	0.993	0.000
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care	0.007	0.993	0.000
N00.9 Unspecified	0.007	0.993	0.000
I34 Nonrheumatic mitral valve disorders	0.007	0.993	0.000
N08.5 Glomerular disorders in systemic connective tissue disorders	0.007	0.993	0.000
N00.8 Other	0.007	0.993	0.000
N00.7 Diffuse crescentic glomerulonephritis	0.007	0.993	0.000
N00.6 Dense deposit disease	0.007	0.993	0.000
N00.5 Diffuse mesangiocapillary glomerulonephritis	0.007	0.993	0.000
N00.4 Diffuse endocapillary proliferative glomerulonephritis	0.007	0.993	0.000
N00.3 Diffuse mesangial proliferative glomerulonephritis	0.007	0.993	0.000
N00.2 Diffuse membranous glomerulonephritis	0.007	0.993	0.000
N00.1 Focal and segmental glomerular lesions	0.007	0.993	0.000
N00.0 Minor glomerular abnormality	0.007	0.993	0.000
N01.9 Unspecified	0.006	0.993	0.000
N01.8 Other	0.006	0.993	0.000
N01.7 Diffuse crescentic glomerulonephritis	0.006	0.993	0.000
N01.6 Dense deposit disease	0.006	0.993	0.000
N01.5 Diffuse mesangiocapillary glomerulonephritis	0.006	0.993	0.000
N01.4 Diffuse endocapillary proliferative glomerulonephritis	0.006	0.993	0.000
N01.3 Diffuse mesangial proliferative glomerulonephritis	0.006	0.993	0.000
N01.2 Diffuse membranous glomerulonephritis	0.006	0.993	0.000
N01.1 Focal and segmental glomerular lesions	0.006	0.993	0.000
N01.0 Minor glomerular abnormality	0.006	0.993	0.000
N06.9 Unspecified	0.006	0.993	0.000
N06.8 Other	0.006	0.993	0.000
N06.7 Diffuse crescentic glomerulonephritis	0.006	0.993	0.000
N06.6 Dense deposit disease	0.006	0.993	0.000
N06.5 Diffuse mesangiocapillary glomerulonephritis	0.006	0.993	0.000
N06.4 Diffuse endocapillary proliferative glomerulonephritis	0.006	0.993	0.000
N06.3 Diffuse mesangial proliferative glomerulonephritis	0.006	0.993	0.000
N06.2 Diffuse membranous glomerulonephritis	0.006	0.993	0.000
N06.1 Focal and segmental glomerular lesions	0.006	0.993	0.000
N06.0 Minor glomerular abnormality	0.006	0.993	0.000
N07.9 Unspecified	0.006	0.993	0.000
N07.8 Other	0.006	0.993	0.000
N07.7 Diffuse crescentic glomerulonephritis	0.006	0.993	0.000
N07.6 Dense deposit disease	0.006	0.993	0.000
N07.5 Diffuse mesangiocapillary glomerulonephritis	0.006	0.993	0.000
N07.4 Diffuse endocapillary proliferative glomerulonephritis	0.006	0.993	0.000
N07.3 Diffuse mesangial proliferative glomerulonephritis	0.006	0.993	0.000
N07.2 Diffuse membranous glomerulonephritis	0.006	0.993	0.000
N07.1 Focal and segmental glomerular lesions	0.006	0.993	0.000
N07.0 Minor glomerular abnormality	0.006	0.993	0.000
E27.1 Primary adrenocortical insufficiency	0.000	0.994	0.006
N02.2 Diffuse membranous glomerulonephritis	0.006	0.994	0.000
Y60.4 During endoscopic examination	0.005	0.995	0.000
Y60.9 During unspecified surgical and medical care	0.005	0.995	0.000
Y60.7 During administration of enema	0.005	0.995	0.000
Y60.6 During aspiration, puncture and other catheterisation	0.005	0.995	0.000
Y60.3 During injection or immunisation	0.005	0.995	0.000
Y60.2 During kidney dialysis or other perfusion	0.005	0.995	0.000
Y60.1 During infusion or transfusion	0.005	0.995	0.000
Y60.5 During heart catheterisation	0.005	0.995	0.000
Y60.8 During other surgical and medical care	0.005	0.995	0.000
E27 Other disorders of adrenal gland	0.000	0.995	0.005
E27.2 Addisonian crisis	0.000	0.995	0.005
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.005	0.995	0.000
I34.8 Other nonrheumatic mitral valve disorders	0.005	0.995	0.000
G99.0 Autonomic neuropathy in endocrine and metabolic diseases	0.005	0.995	0.000
G63 Polyneuropathy in diseases classified elsewhere	0.005	0.995	0.000
I34.2 Nonrheumatic mitral (valve) stenosis	0.005	0.995	0.000
N03 Chronic nephritic syndrome	0.005	0.995	0.000
I34.9 Nonrheumatic mitral valve disorder, unspecified	0.004	0.996	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.996	0.004
K82.4 Cholesterolosis of gallbladder	0.004	0.996	0.000
W18.3 Sports and athletics area	0.004	0.996	0.000
B25.9 Cytomegaloviral disease, unspecified	0.004	0.996	0.000
N30.3 Trigonitis	0.004	0.996	0.000
M19.96 Arthrosis, unspecified-Lower leg	0.004	0.996	0.000
I34.1 Mitral (valve) prolapse	0.004	0.996	0.000
K72.9 Hepatic failure, unspecified	0.000	0.996	0.004
E27.9 Disorder of adrenal gland, unspecified	0.000	0.996	0.004
E27.3 Drug-induced adrenocortical insufficiency	0.000	0.996	0.004
S02.50 Fracture of tooth (closed)	0.004	0.996	0.000
E83.3 Disorders of phosphorus metabolism	0.004	0.996	0.000
E27.8 Other specified disorders of adrenal gland	0.000	0.996	0.004
E27.5 Adrenomedullary hyperfunction	0.000	0.996	0.004
E27.0 Other adrenocortical overactivity	0.000	0.996	0.004
E83 Disorders of mineral metabolism	0.004	0.996	0.000
O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.004	0.996	0.000
O99.2 Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium	0.004	0.996	0.000
G63.8 Polyneuropathy in other diseases classified elsewhere	0.004	0.996	0.000
G63.6 Polyneuropathy in other musculoskeletal disorders	0.004	0.996	0.000
G63.5 Polyneuropathy in systemic connective tissue disorders	0.004	0.996	0.000
G63.4 Polyneuropathy in nutritional deficiency	0.004	0.996	0.000
G63.3 Polyneuropathy in other endocrine and metabolic diseases	0.004	0.996	0.000
G63.1 Polyneuropathy in neoplastic disease	0.004	0.996	0.000
G63.0 Polyneuropathy in infectious and parasitic diseases classified elsewhere	0.004	0.996	0.000
Z53.2 Procedure not carried out because of patient's decision for other and unspecified reasons	0.000	0.996	0.004
I25.2 Old myocardial infarction	0.004	0.996	0.000
N03.8 Other	0.003	0.996	0.000
N03.7 Diffuse crescentic glomerulonephritis	0.003	0.996	0.000
N03.6 Dense deposit disease	0.003	0.996	0.000
N03.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.996	0.000
N03.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.996	0.000
N03.2 Diffuse membranous glomerulonephritis	0.003	0.996	0.000
N03.0 Minor glomerular abnormality	0.003	0.996	0.000
N03.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.997	0.000
L03.8 Cellulitis of other sites	0.003	0.997	0.000
I24 Other acute ischaemic heart diseases	0.003	0.997	0.000
K38.8 Other specified diseases of appendix	0.003	0.997	0.000
O99.1 Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
I10 Essential (primary) hypertension	0.003	0.997	0.000
I25.8 Other forms of chronic ischaemic heart disease	0.003	0.997	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.003	0.997	0.000
Y60-Y69 Misadventures to patients during surgical and medical care	0.003	0.997	0.000
O99.3 Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
S22.20 Fracture of sternum (closed)	0.000	0.997	0.003
N03.1 Focal and segmental glomerular lesions	0.003	0.997	0.000
B25 Cytomegaloviral disease	0.003	0.997	0.000
B25.8 Other cytomegaloviral diseases	0.003	0.997	0.000
O99.5 Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
M79.66 Pain in limb (Lower leg)	0.003	0.997	0.000
E83.9 Disorder of mineral metabolism, unspecified	0.003	0.997	0.000
E83.8 Other disorders of mineral metabolism	0.003	0.997	0.000
E83.2 Disorders of zinc metabolism	0.003	0.997	0.000
E83.0 Disorders of copper metabolism	0.003	0.997	0.000
Y45.2 Propionic acid derivatives	0.003	0.997	0.000
I24.1 Dressler's syndrome	0.003	0.997	0.000
O99.4 Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
Y45.1 Salicylates	0.003	0.997	0.000
Z92.1 Personal history of long-term (current) use of anticoagulants	0.003	0.997	0.000
M79.85 Other specified soft tissue disorders (Pelvic region and thigh)	0.003	0.997	0.000
T23.3 Burn of third degree of wrist and hand	0.003	0.997	0.000
Y45.8 Other analgesics and antipyretics	0.003	0.997	0.000
G43 Migraine	0.003	0.997	0.000
Z36.8 Other antenatal screening	0.003	0.997	0.000
Z29.0 Isolation	0.000	0.997	0.003
B35.3 Tinea pedis	0.003	0.997	0.000
Y45.4 Antirheumatics	0.003	0.997	0.000
Y64 Contaminated medical or biological substances	0.003	0.997	0.000
Y63 Failure in dosage during surgical and medical care	0.003	0.997	0.000
Y62 Failure of sterile precautions during surgical and medical care	0.003	0.997	0.000
Y69 Unspecified misadventure during surgical and medical care	0.003	0.997	0.000
Y66 Nonadministration of surgical and medical care	0.003	0.997	0.000
N20.2 Calculus of kidney with calculus of ureter	0.003	0.997	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.003	0.997	0.000
J45.9 Asthma, unspecified	0.003	0.997	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
Y45.5 4-Aminophenol derivatives	0.003	0.997	0.000
Z91.6 Personal history of other physical trauma	0.000	0.997	0.003
B25.2 Cytomegaloviral pancreatitis	0.002	0.997	0.000
B25.1 Cytomegaloviral hepatitis	0.002	0.997	0.000
B25.0 Cytomegaloviral pneumonitis	0.002	0.997	0.000
Y61 Foreign object accidentally left in body during surgical and medical care	0.002	0.997	0.000
M67.8 Other specified disorders of synovium and tendon	0.003	0.997	0.000
Y65 Other misadventures during surgical and medical care	0.002	0.997	0.000
N02.9 Unspecified	0.002	0.997	0.000
Z71.3 Dietary counselling and surveillance	0.003	0.997	0.000
T84.6 Infection and inflammatory reaction due to internal fixation device [any site]	0.003	0.997	0.000
G61.0 Guillain-Barre syndrome	0.002	0.998	0.000
S43.0 Dislocation of shoulder joint	0.002	0.998	0.000
O99.7 Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
W18 Other fall on same level	0.002	0.998	0.000
S22.40 Multiple fractures of ribs (closed)	0.000	0.998	0.002
H01.0 Blepharitis	0.002	0.998	0.000
I11.9 Hypertensive heart disease without (congestive) heart failure	0.002	0.998	0.000
R23.2 Flushing	0.000	0.998	0.002
I11 Hypertensive heart disease	0.002	0.998	0.000
G43.0 Migraine without aura [common migraine]	0.002	0.998	0.000
S22.2 Fracture of sternum	0.000	0.998	0.002
G43.2 Status migrainosus	0.002	0.998	0.000
O24.0 Pre-existing diabetes mellitus, insulin-dependent	0.002	0.998	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
I10-I15 Hypertensive diseases	0.002	0.998	0.000
W18.6 Industrial and construction area	0.002	0.998	0.000
Y65.8 Other specified misadventures during surgical and medical care	0.002	0.998	0.000
C18.3 Hepatic flexure	0.000	0.998	0.002
K65.8 Other peritonitis	0.000	0.998	0.002
C71.9 Brain, unspecified	0.000	0.998	0.002
J94.8 Other specified pleural conditions	0.002	0.998	0.000
Y62.9 During unspecified surgical and medical care	0.002	0.998	0.000
Y62.8 During other surgical and medical care	0.002	0.998	0.000
Y62.6 During aspiration, puncture and other catheterisation	0.002	0.998	0.000
Y62.5 During heart catheterisation	0.002	0.998	0.000
Y62.4 During endoscopic examination	0.002	0.998	0.000
Y62.3 During injection or immunisation	0.002	0.998	0.000
Y62.2 During kidney dialysis or other perfusion	0.002	0.998	0.000
Y62.1 During infusion or transfusion	0.002	0.998	0.000
Y62.0 During surgical operation	0.002	0.998	0.000
Y63.9 Failure in dosage during unspecified surgical and medical care	0.002	0.998	0.000
Y63.8 Failure in dosage during other surgical and medical care	0.002	0.998	0.000
Y63.6 Nonadministration of necessary drug, medicament or biological substance	0.002	0.998	0.000
Y63.5 Inappropriate temperature in local application and packing	0.002	0.998	0.000
Y63.4 Failure in dosage in electroshock or insulin-shock therapy	0.002	0.998	0.000
Y63.3 Inadvertent exposure of patient to radiation during medical care	0.002	0.998	0.000
Y63.2 Overdose of radiation given during therapy	0.002	0.998	0.000
Y63.1 Incorrect dilution of fluid used during infusion	0.002	0.998	0.000
Y63.0 Excessive amount of blood or other fluid given during transfusion or infusion	0.002	0.998	0.000
Y64.9 Contaminated medical or biological substance administered by unspecified means	0.002	0.998	0.000
Y64.8 Contaminated medical or biological substance administered by other means	0.002	0.998	0.000
Y64.1 Contaminated medical or biological substance, injected or used for immunisation	0.002	0.998	0.000
Y64.0 Contaminated medical or biological substance, transfused or infused	0.002	0.998	0.000
N94.4 Primary dysmenorrhoea	0.000	0.998	0.002
I13 Hypertensive heart and renal disease	0.002	0.998	0.000
G43.3 Complicated migraine	0.002	0.998	0.000
Y61.9 During unspecified surgical and medical care	0.002	0.998	0.000
Y61.8 During other surgical and medical care	0.002	0.998	0.000
Y61.7 During removal of catheter or packing	0.002	0.998	0.000
Y61.6 During aspiration, puncture and other catheterisation	0.002	0.998	0.000
Y61.5 During heart catheterisation	0.002	0.998	0.000
Y61.4 During endoscopic examination	0.002	0.998	0.000
Y61.3 During injection or immunisation	0.002	0.998	0.000
Y61.2 During kidney dialysis or other perfusion	0.002	0.998	0.000
Y61.1 During infusion or transfusion	0.002	0.998	0.000
M65.34 Trigger finger-Hand	0.000	0.998	0.002
Y65.5 Performance of inappropriate operation	0.002	0.998	0.000
Y65.3 Endotracheal tube wrongly placed during anaesthetic procedure	0.002	0.998	0.000
Y65.2 Failure in suture or ligature during surgical operation	0.002	0.998	0.000
Y65.1 Wrong fluid used in infusion	0.002	0.998	0.000
Y65.0 Mismatched blood used in transfusion	0.002	0.998	0.000
C78.2 Secondary malignant neoplasm of pleura	0.002	0.998	0.000
R44.0 Auditory hallucinations	0.002	0.998	0.000
E85.9 Amyloidosis, unspecified	0.002	0.998	0.000
Y61.0 During surgical operation	0.002	0.998	0.000
W18.9 Unspecified place	0.002	0.998	0.000
W18.8 Other specified place	0.002	0.998	0.000
W18.4 Street and highway	0.002	0.998	0.000
W18.2 School, other institution and public administrative area	0.002	0.998	0.000
W18.0 Home	0.002	0.998	0.000
W18.7 Farm	0.002	0.998	0.000
Z35.2 Supervision of pregnancy with other poor reproductive or obstetric history	0.002	0.998	0.000
I11.0 Hypertensive heart disease with (congestive) heart failure	0.002	0.998	0.000
Y42.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
I99 Other and unspecified disorders of circulatory system	0.002	0.998	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
B35.1 Tinea unguium	0.002	0.998	0.000
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure	0.002	0.998	0.000
I13.9 Hypertensive heart and renal disease, unspecified	0.002	0.998	0.000
I15 Secondary hypertension	0.002	0.998	0.000
M40.24 Other and unspecified kyphosis (Thoracic region)	0.002	0.998	0.000
S22.21 Fracture of sternum (open)	0.000	0.998	0.002
B35 Dermatophytosis	0.002	0.998	0.000
E85 Amyloidosis	0.002	0.998	0.000
W18.5 Trade and service area	0.002	0.998	0.000
K38 Other diseases of appendix	0.002	0.998	0.000
I15.9 Seconday hypertension, unspecified	0.002	0.998	0.000
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.002	0.998	0.000
S22.4 Multiple fractures of ribs	0.000	0.998	0.002
G61 Inflammatory polyneuropathy	0.002	0.998	0.000
C82.0 Small cleaved cell, follicular	0.002	0.998	0.000
K72 Hepatic failure, not elsewhere classified	0.000	0.998	0.002
R80 Isolated proteinuria	0.002	0.998	0.000
S12.90 Fracture of neck, part unspecified (closed)	0.000	0.998	0.002
Y65.4 Failure to introduce or to remove other tube or instrument	0.002	0.998	0.000
E85.3 Secondary systemic amyloidosis	0.002	0.998	0.000
W18.1 Residential institution	0.002	0.998	0.000
S12.10 Fracture of second cervical vertebra (closed)	0.000	0.998	0.002
I13.1 Hypertensive heart and renal disease with renal failure	0.002	0.998	0.000
I13.0 Hypertensive heart and renal disease with (congestive) heart failure	0.002	0.998	0.000
Y44.2 Anticoagulants	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
S02.5 Fracture of tooth	0.002	0.998	0.000
Q23.1 Congenital insufficiency of aortic valve	0.002	0.998	0.000
L92.9 Granulomatous disorder of skin and subcutaneous tissue, unspecified	0.002	0.998	0.000
C71.8 Overlapping lesion of brain	0.000	0.998	0.002
E85.4 Organ-limited amyloidosis	0.002	0.998	0.000
G43.8 Other migraine	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.002	0.998	0.000
M40.29 Other and unspecified kyphosis (Site unspecified)	0.002	0.998	0.000
W18.09 Other fall on same level: Home: During unspecified activity	0.001	0.998	0.000
W18.04 Other fall on same level, Home , While resting, sleeping, eating or engaging in other vital activities	0.001	0.998	0.000
W18.22 Other fall on same level; School, other institution and public administrative area; While working for income	0.001	0.998	0.000
W18.49 Other fall on same level; Street and highway; During unspecified activity	0.001	0.998	0.000
W18.48 Other fall on same level; Street and highway; While engaged in other specified activities	0.001	0.998	0.000
W18.89 Other fall on same level; Other specified places; During unspecified activity	0.001	0.998	0.000
W18.99 Other fall on same level; Unspecified place; During unspecified activity	0.001	0.998	0.000
W18.93 Other fall on same level; Unspecified place; While engaged in other types of work	0.001	0.998	0.000
G44.2 Tension-type headache	0.002	0.998	0.000
K38.9 Disease of appendix, unspecified	0.002	0.998	0.000
G99 Other disorders of nervous system in diseases classified elsewhere	0.002	0.998	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.002	0.998	0.000
J01.9 Acute sinusitis, unspecified	0.002	0.998	0.000
Y42.4 Oral contraceptives	0.002	0.998	0.000
Y42.1 Thyroid hormones and substitutes	0.002	0.998	0.000
C82.3 Follicular lymphoma grade IIIa	0.002	0.998	0.000
V04.1 Traffic accident	0.002	0.998	0.000
Y42.2 Antithyroid drugs	0.002	0.998	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
I15.8 Other secondary hypertension	0.002	0.998	0.000
I15.2 Hypertension secondary to endocrine disorders	0.002	0.998	0.000
M79.8 Other specified soft tissue disorders	0.002	0.998	0.000
Y45.0 Opioids and related analgesics	0.002	0.998	0.000
Z29 Need for other prophylactic measures	0.000	0.998	0.002
B35.9 Dermatophytosis, unspecified	0.002	0.998	0.000
B35.8 Other dermatophytoses	0.002	0.998	0.000
B35.6 Tinea cruris	0.002	0.998	0.000
B35.5 Tinea imbricata	0.002	0.998	0.000
B35.4 Tinea corporis	0.002	0.998	0.000
B35.2 Tinea manuum	0.002	0.998	0.000
B35.0 Tinea barbae and tinea capitis	0.002	0.998	0.000
E85.2 Heredofamilial amyloidosis, unspecified	0.002	0.998	0.000
E85.1 Neuropathic heredofamilial amyloidosis	0.002	0.998	0.000
E85.0 Nonneuropathic heredofamilial amyloidosis	0.002	0.998	0.000
I97.8 Other postprocedural disorders of circulatory system, not elsewhere classified	0.002	0.998	0.000
M40.2 Other and unspecified kyphosis	0.002	0.998	0.000
R81 Glycosuria	0.002	0.998	0.000
G61.9 Inflammatory polyneuropathy, unspecified	0.002	0.998	0.000
K38.3 Fistula of appendix	0.001	0.998	0.000
K38.2 Diverticulum of appendix	0.001	0.998	0.000
K38.0 Hyperplasia of appendix	0.002	0.998	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.002	0.998	0.000
I25 Chronic ischaemic heart disease	0.002	0.998	0.000
S22.41 Multiple fractures of ribs (open)	0.000	0.998	0.001
C44.1 Skin of eyelid, including canthus	0.002	0.998	0.000
G61.1 Serum neuropathy	0.001	0.998	0.000
Z29.2 Other prophylactic chemotherapy	0.000	0.998	0.002
O94-O99 Other obstetric conditions, not elsewhere classified	0.002	0.998	0.000
E85.8 Other amyloidosis	0.001	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.002
Y51 Drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
M79.81 Other specified soft tissue disorders (Shoulder region)	0.002	0.998	0.000
E73.9 Lactose intolerance, unspecified	0.002	0.998	0.000
T18.5 Foreign body in anus and rectum	0.002	0.998	0.000
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.001	0.998	0.000
M87.20 Osteonecrosis due to previous trauma (Multiple sites)	0.002	0.998	0.000
C82.2 Large cell, follicular	0.002	0.998	0.000
Y00.9 Unspecified place	0.002	0.998	0.000
S02.51 Fracture of tooth (open)	0.001	0.998	0.000
S12.70 Multiple fractures of cervical spine (closed)	0.000	0.998	0.002
I65.2 Occlusion and stenosis of carotid artery	0.000	0.998	0.002
K72.1 Chronic hepatic failure	0.000	0.998	0.001
Y44.9 Other and unspecified agents affecting blood constituents	0.001	0.998	0.000
Y44.7 Plasma substitutes	0.001	0.998	0.000
Y44.6 Natural blood and blood products	0.001	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.001	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.001	0.998	0.000
C71 Malignant neoplasm of brain	0.000	0.998	0.002
S62.80 Fracture of other and unspecified parts of wrist and hand (closed)	0.000	0.998	0.002
C71.3 Parietal lobe	0.000	0.998	0.002
I15.1 Hypertension secondary to other renal disorders	0.001	0.998	0.000
I15.0 Renovascular hypertension	0.001	0.998	0.000
K58.9 Irritable bowel syndrome without diarrhoea	0.002	0.998	0.000
K72.0 Acute and subacute hepatic failure	0.000	0.998	0.002
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.002	0.998	0.000
A60.0 Herpesviral infection of genitalia and urogenital tract	0.001	0.998	0.000
I25.4 Coronary artery aneurysm	0.001	0.998	0.000
S12.9 Fracture of neck, part unspecified	0.000	0.998	0.001
E73 Lactose intolerance	0.001	0.998	0.000
Y79.2 Prosthetic and other implants, materials and accessory devices	0.001	0.998	0.000
S22 Fracture of rib(s), sternum and thoracic spine	0.000	0.998	0.001
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.002	0.998	0.000
G99.8 Other specified disorders of nervous system in diseases classified elsewhere	0.001	0.998	0.000
G99.1 Other disorders of autonomic nervous system in other diseases classified elsewhere	0.001	0.998	0.000
L91.8 Other hypertrophic disorders of skin	0.002	0.998	0.000
R84.5 Abnormal microbiological findings	0.000	0.998	0.001
S12.1 Fracture of second cervical vertebra	0.000	0.998	0.001
S22.1 Multiple fractures of thoracic spine	0.000	0.998	0.001
E70-E90 Metabolic disorders	0.002	0.998	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.002	0.998	0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.000	0.998	0.001
S22.10 Multiple fractures of thoracic spine (closed)	0.000	0.998	0.001
M40.26 Other and unspecified kyphosis (Lumbar region)	0.001	0.999	0.000
Z29.9 Prophylactic measure, unspecified	0.000	0.999	0.001
M40.28 Other and unspecified kyphosis (Sacral and sacrococcygeal region)	0.001	0.999	0.000
M40.27 Other and unspecified kyphosis (Lumbosacral region)	0.001	0.999	0.000
M40.25 Other and unspecified kyphosis (Thoracolumbar region)	0.001	0.999	0.000
M40.23 Other and unspecified kyphosis (Cervicothoracic region)	0.001	0.999	0.000
M40.22 Other and unspecified kyphosis (Cervical region)	0.001	0.999	0.000
M40.21 Other and unspecified kyphosis (Occipito-atlanto-axial region)	0.001	0.999	0.000
M40.20 Other and unspecified kyphosis (Multiple sites in spine)	0.001	0.999	0.000
M79.64 Pain in limb (Hand)	0.001	0.999	0.000
V17.4 Driver injured in traffic accident	0.001	0.999	0.000
Y42.5 Other oestrogens and progestogens	0.001	0.999	0.000
Z29.1 Prophylactic immunotherapy	0.000	0.999	0.001
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.001	0.999	0.000
I25.6 Silent myocardial ischaemia	0.001	0.999	0.000
Y46.4 Iminostilbenes	0.001	0.999	0.000
O97 Death from sequelae of direct obstetric causes	0.001	0.999	0.000
O96 Death from any obstetric cause occurring more than 42 days but less than one year after delivery	0.001	0.999	0.000
O95 Obstetric death of unspecified cause	0.001	0.999	0.000
O94 Sequelae of complication of pregnancy, childbirth and the puerperium	0.001	0.999	0.000
Y58 Bacterial vaccines	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations